Status:
COMPLETED
Involvement of Reticulum Endoplasmic Stress in the Physiopathology of Polycystic Ovary Syndrome
Lead Sponsor:
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The main objective of the present project is to evaluate the relevance of reticulum stress in the pathogenesis of polycystic ovary syndrome (PCOS), focusing particularly on the underlying mechanisms o...
Detailed Description
To do this, the investigators will evaluate anthropometric, biochemical and hormone parameters, lipid profile and cardiovascular risk markers (using enzymatic and biochemical techniques, nephelometry,...
Eligibility Criteria
Inclusion
- Women diagnosed with PCOS using the Rotterdam criteria
- Women of reproductive age
Exclusion
- Organic, malignant, haematological, infectious or inflammatory disease
- History of ischaemic heart disease (stroke or thromboembolism)
- Diabetes mellitus,
- Secondary causes of obesity (hypothyroidism, Cushing's syndrome)
- Severe hypertension.
- Smoking or alcohol habit
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02302326
Start Date
January 1 2013
End Date
December 1 2019
Last Update
February 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antonio Hernández
Valencia, Spain, 46017